Targeting NTRK1 Enhances Immune Checkpoint Inhibitor Efficacy in NTRK1 Wild-Type Non–Small Cell Lung Cancer

Margaret Smith(Wake Forest University), Fei Xing(Southern Illinois University School of Medicine)
Cancer Research
September 9, 2024
Cited by 11


Related Papers